メチシリン耐性黄色ブドウ球菌（MRSA）治療薬の世界市場（～2026年）

• 英文タイトル：Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY07689 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料はメチシリン耐性黄色ブドウ球菌（MRSA）治療薬のグローバル市場について調査・分析したレポートです。種類別（バクトリム、バンコマイシン、クリンダマイシン、ミノサイクリン）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別メチシリン耐性黄色ブドウ球菌（MRSA）治療薬の競争状況、市場シェア ・世界のメチシリン耐性黄色ブドウ球菌（MRSA）治療薬市場：種類別市場規模 2015年-2020年（バクトリム、バンコマイシン、クリンダマイシン、ミノサイクリン） ・世界のメチシリン耐性黄色ブドウ球菌（MRSA）治療薬市場：種類別市場規模予測 2021年-2026年（バクトリム、バンコマイシン、クリンダマイシン、ミノサイクリン） ・世界のメチシリン耐性黄色ブドウ球菌（MRSA）治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界のメチシリン耐性黄色ブドウ球菌（MRSA）治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米のメチシリン耐性黄色ブドウ球菌（MRSA）治療薬市場分析：米国、カナダ ・ヨーロッパのメチシリン耐性黄色ブドウ球菌（MRSA）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのメチシリン耐性黄色ブドウ球菌（MRSA）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のメチシリン耐性黄色ブドウ球菌（MRSA）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのメチシリン耐性黄色ブドウ球菌（MRSA）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Takeda Pharmaceutical、Merck、AstraZeneca、GlaxoSmithKline、Pfizer、Cubist Pharmaceuticals、ViroPharma、Forest Laboratories、Theravance ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market
The global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Scope and Market Size
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market is segmented into
Bactrim
Vancomycin
Clindamycin
Minocycline

Segment by Application, the Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market is segmented into
Hospital
Clinic

Regional and Country-level Analysis
The Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share Analysis
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs business, the date to enter into the Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market, Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs product introduction, recent developments, etc.

The major vendors covered:
Takeda Pharmaceutical
Merck
AstraZeneca
GlaxoSmithKline
Pfizer
Cubist Pharmaceuticals
ViroPharma
Forest Laboratories
Theravance

レポート目次

---

1 Study Coverage
1.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product Introduction
1.2 Market Segments
1.3 Key Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by Type
1.4.2 Bactrim
1.4.3 Vancomycin
1.4.4 Clindamycin
1.4.5 Minocycline
1.5 Market by Application
1.5.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue 2015-2026
2.1.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales 2015-2026
2.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Competitor Landscape by Players
3.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturers
3.1.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturers
3.2.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue in 2019
3.2.5 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price by Manufacturers
3.4 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Type (2015-2020)
4.1.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2015-2020)
4.1.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Type (2015-2020)
4.1.3 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Application (2015-2020)
5.1.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2015-2020)
5.1.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Application (2015-2020)
5.1.3 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price by Application (2015-2020)
5.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs by Country
6.1.1 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country
6.1.2 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Type
6.3 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs by Country
7.1.1 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country
7.1.2 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Type
7.3 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs by Region
8.1.1 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Region
8.1.2 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs by Country
9.1.1 Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country
9.1.2 Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Type
9.3 Central & South America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs by Country
10.1.1 Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country
10.1.2 Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Corporation Information
11.1.2 Takeda Pharmaceutical Description and Business Overview
11.1.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Takeda Pharmaceutical Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.1.5 Takeda Pharmaceutical Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Description and Business Overview
11.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Merck Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.2.5 Merck Related Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Corporation Information
11.3.2 AstraZeneca Description and Business Overview
11.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AstraZeneca Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.3.5 AstraZeneca Related Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Description and Business Overview
11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.4.5 GlaxoSmithKline Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.5.5 Pfizer Related Developments
11.6 Cubist Pharmaceuticals
11.6.1 Cubist Pharmaceuticals Corporation Information
11.6.2 Cubist Pharmaceuticals Description and Business Overview
11.6.3 Cubist Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Cubist Pharmaceuticals Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.6.5 Cubist Pharmaceuticals Related Developments
11.7 ViroPharma
11.7.1 ViroPharma Corporation Information
11.7.2 ViroPharma Description and Business Overview
11.7.3 ViroPharma Sales, Revenue and Gross Margin (2015-2020)
11.7.4 ViroPharma Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.7.5 ViroPharma Related Developments
11.8 Forest Laboratories
11.8.1 Forest Laboratories Corporation Information
11.8.2 Forest Laboratories Description and Business Overview
11.8.3 Forest Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Forest Laboratories Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.8.5 Forest Laboratories Related Developments
11.9 Theravance
11.9.1 Theravance Corporation Information
11.9.2 Theravance Description and Business Overview
11.9.3 Theravance Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Theravance Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.9.5 Theravance Related Developments
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Corporation Information
11.1.2 Takeda Pharmaceutical Description and Business Overview
11.1.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Takeda Pharmaceutical Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Products Offered
11.1.5 Takeda Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Estimates and Projections by Region
12.1.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Segments
Table 2. Ranking of Global Top Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Bactrim
Table 5. Major Manufacturers of Vancomycin
Table 6. Major Manufacturers of Clindamycin
Table 7. Major Manufacturers of Minocycline
Table 8. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Regions 2015-2020 (K Units)
Table 11. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs as of 2019)
Table 17. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Price (2015-2020) (US$/Unit)
Table 20. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product Type
Table 22. Date of International Manufacturers Enter into Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2015-2020) (K Units)
Table 25. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Type (2015-2020)
Table 26. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Share by Type (2015-2020)
Table 28. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)
Table 29. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Application (2015-2020)
Table 31. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2015-2020) (K Units)
Table 32. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2015-2020) (K Units)
Table 36. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2015-2020) (K Units)
Table 38. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2015-2020) (K Units)
Table 40. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2015-2020) (K Units)
Table 44. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2015-2020) (K Units)
Table 46. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2015-2020) (K Units)
Table 56. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2015-2020) (K Units)
Table 60. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2015-2020) (K Units)
Table 62. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2015-2020)
Table 71. Takeda Pharmaceutical Corporation Information
Table 72. Takeda Pharmaceutical Description and Major Businesses
Table 73. Takeda Pharmaceutical Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 74. Takeda Pharmaceutical Product
Table 75. Takeda Pharmaceutical Recent Development
Table 76. Merck Corporation Information
Table 77. Merck Description and Major Businesses
Table 78. Merck Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 79. Merck Product
Table 80. Merck Recent Development
Table 81. AstraZeneca Corporation Information
Table 82. AstraZeneca Description and Major Businesses
Table 83. AstraZeneca Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 84. AstraZeneca Product
Table 85. AstraZeneca Recent Development
Table 86. GlaxoSmithKline Corporation Information
Table 87. GlaxoSmithKline Description and Major Businesses
Table 88. GlaxoSmithKline Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 89. GlaxoSmithKline Product
Table 90. GlaxoSmithKline Recent Development
Table 91. Pfizer Corporation Information
Table 92. Pfizer Description and Major Businesses
Table 93. Pfizer Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 94. Pfizer Product
Table 95. Pfizer Recent Development
Table 96. Cubist Pharmaceuticals Corporation Information
Table 97. Cubist Pharmaceuticals Description and Major Businesses
Table 98. Cubist Pharmaceuticals Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 99. Cubist Pharmaceuticals Product
Table 100. Cubist Pharmaceuticals Recent Development
Table 101. ViroPharma Corporation Information
Table 102. ViroPharma Description and Major Businesses
Table 103. ViroPharma Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 104. ViroPharma Product
Table 105. ViroPharma Recent Development
Table 106. Forest Laboratories Corporation Information
Table 107. Forest Laboratories Description and Major Businesses
Table 108. Forest Laboratories Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 109. Forest Laboratories Product
Table 110. Forest Laboratories Recent Development
Table 111. Theravance Corporation Information
Table 112. Theravance Description and Major Businesses
Table 113. Theravance Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 114. Theravance Product
Table 115. Theravance Recent Development
Table 116. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 117. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 121. North America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 123. Europe: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 125. Asia Pacific: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 127. Latin America: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 129. Middle East and Africa: Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Players
Table 134. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Customers List
Table 135. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Product Picture
Figure 2. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Bactrim Product Picture
Figure 4. Vancomycin Product Picture
Figure 5. Clindamycin Product Picture
Figure 6. Minocycline Product Picture
Figure 7. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Report Years Considered
Figure 11. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales 2015-2026 (K Units)
Figure 13. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Region in 2019
Figure 16. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Region in 2019
Figure 18. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue in 2019
Figure 20. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Type in 2019
Figure 23. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Type in 2019
Figure 25. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Application in 2019
Figure 28. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Application in 2019
Figure 30. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 31. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country in 2019
Figure 33. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.S. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. Canada Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Type in 2019
Figure 39. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Application in 2019
Figure 40. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 41. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country in 2019
Figure 43. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Germany Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. France Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. U.K. Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Italy Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Russia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Type in 2019
Figure 55. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 57. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Region in 2019
Figure 60. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. China Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. South Korea Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. India Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Australia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Taiwan Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Indonesia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Thailand Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Malaysia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Philippines Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Vietnam Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Application in 2019
Figure 84. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 85. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Mexico Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Brazil Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Argentina Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Type in 2019
Figure 95. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 97. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Turkey Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Saudi Arabia Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. UAE Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. UAE Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Share by Application in 2019
Figure 108. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. North America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Asia Pacific Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Latin America Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Middle East and Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed

---